SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals informs about company updates

10 Jun 2019 Evaluate

Vista Pharmaceuticals has informed that 5,00,000 and 2,00,000 convertible warrants of Mukesh Chamdia (non-promoter) and S & A Corporate Advisory (non-promoter) respectively, due for conversion into equity shares have not been converted in stipulated time, hence lapsed and upfront money received on the aforesaid warrants are forfeited by the company in accordance with SEBI (ICDR) Regulations.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

7.75 0.24 (3.20%)
20-Apr-2026 09:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1676.00
Dr. Reddys Lab 1235.40
Cipla 1235.05
Zydus Lifesciences 941.20
Lupin 2330.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×